Medical Properties Trust (NYSE:MPW) announced its quarterly earnings results on Thursday. The real estate investment trust reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.01, Briefing.com reports. Medical Properties Trust had a return on equity of 9.12% and a net margin of 44.46%. The firm had revenue of $197.00 million for the quarter, compared to analysts’ expectations of $192.64 million. During the same period in the prior year, the business posted $0.33 earnings per share. The business’s revenue was up 11.6% compared to the same quarter last year.
Shares of MPW stock opened at $15.34 on Friday. The company has a current ratio of 2.19, a quick ratio of 2.19 and a debt-to-equity ratio of 1.26. The firm has a market cap of $5.42 billion, a PE ratio of 11.36, a price-to-earnings-growth ratio of 3.09 and a beta of 0.47. Medical Properties Trust has a 52 week low of $11.82 and a 52 week high of $15.57.
The firm also recently announced a quarterly dividend, which was paid on Thursday, October 11th. Stockholders of record on Thursday, September 13th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 6.52%. The ex-dividend date was Wednesday, September 12th. Medical Properties Trust’s payout ratio is presently 74.07%.
Hedge funds have recently made changes to their positions in the company. Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new stake in shares of Medical Properties Trust during the second quarter worth $104,000. Cornerstone Wealth Management LLC bought a new stake in shares of Medical Properties Trust during the second quarter worth $583,000. Valeo Financial Advisors LLC bought a new stake in shares of Medical Properties Trust during the second quarter worth $128,000. Integrated Investment Consultants LLC bought a new stake in shares of Medical Properties Trust during the second quarter worth $136,000. Finally, Investors Asset Management of Georgia Inc. GA ADV bought a new stake in shares of Medical Properties Trust during the second quarter worth $140,000. Institutional investors own 76.88% of the company’s stock.
A number of brokerages have weighed in on MPW. Stifel Nicolaus set a $14.00 price target on Medical Properties Trust and gave the company a “hold” rating in a research report on Thursday. Mitsubishi UFJ Financial Group upped their price target on Medical Properties Trust to $15.00 and gave the company a “neutral” rating in a research report on Friday. Zacks Investment Research cut Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Thursday, October 25th. Jefferies Financial Group cut Medical Properties Trust from a “buy” rating to a “hold” rating and set a $15.00 price target on the stock. in a research report on Tuesday, July 17th. Finally, JMP Securities set a $16.00 price target on Medical Properties Trust and gave the company a “buy” rating in a research report on Monday, October 1st. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company’s stock. Medical Properties Trust has an average rating of “Hold” and an average target price of $14.28.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Article: How can you know how many shares are floating?
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.